Back to search

Article

Individualized ctDNA Fingerprints to Monitor Treatment Response and Recurrence in Multiple Cancer Types

2019-08-12

Abstract excerpt

Circulating tumor DNA (ctDNA) panels hold high promise of accurately predicting the therapeutic response of tumors while being minimally invasive and cost-efficient. However, their use has been limited to a small number of tumor types and patients. Here, we developed individualized ctDNA fingerprints suitable for most patients with multiple cancer types. The panels were designed based on individual whole-exome seq...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8ee6146f-a8b1-5112-aecd-0c5518cf4f92
DOI
10.1101/732503
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Individualized ctDNA Fingerprints to Monitor Treatment Response and Recurrence in Multiple Cancer TypesDOI 10.1101/732503
Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors.Semantic proximity
Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types.Semantic proximity
Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients.Semantic proximity
Dynamic Analysis of Circulating Tumor DNA to Predict the Prognosis and Monitor the Treatment Response of Patients with Metastatic Triple-negative Breast Cancer: a prospective studySemantic proximity
Comprehensive landscape and interference of clonal haematopoiesis mutations for liquid biopsy: A Chinese pan-cancer cohort.Semantic proximity
Noninvasive MRD monitoring and profiling of clonal evolution by ctDNA in patients with advanced cancers treated within molecular tumor boardsSemantic proximity
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1,000 Chinese patients with cancerSemantic proximity
Application of clinical genomic sequencing among Chinese advanced cancer patients to guide precision medicine decisionsSemantic proximity
Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study.Semantic proximity
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancerSemantic proximity
Molecular characterization of ctDNA from Chinese patients with advanced gastric adenocarcinoma reveals actionable alterations for targeted and immune therapy.Semantic proximity
Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA.Semantic proximity
Select a neighboring publication to make it the new centre.